JFS Wealth Advisors
PCVX icon

JFS Wealth Advisors’s Vaxcyte PCVX Stock Holding History

JFS Wealth Advisors’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.39K Buy
42
+37
+740% +$2.16K ﹤0.01% 1539
2026
Q2 		$291 Buy
+5
New +$272 ﹤0.01% 2069
2025
Q1 		– Sell
-1
Closed -$82 – 1978
2024
Q4 		$82 Buy
+1
New +$99 ﹤0.01% 1895

Other funds holding PCVX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

JFS Wealth Advisors's PCVX Position: Q3 2026 in Review

JFS Wealth Advisors increased its Vaxcyte (PCVX) stake by 740% in Q3 2026, buying an estimated $2.16K and bringing the position to 42 shares worth $2.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1539.

JFS Wealth Advisors first reported a position in PCVX in Q4 2024 and has held it in 3 quarters since. 127 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • JFS Wealth Advisors held 42 shares of Vaxcyte worth $2.39K as of Q3 2026.
  • JFS Wealth Advisors bought 37 Vaxcyte shares in Q3 2026, an estimated $2.16K.
  • Vaxcyte made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q3 2026, its #1539 holding.
  • JFS Wealth Advisors first reported a position in Vaxcyte in Q4 2024 and has held it in 3 quarters since.
  • 127 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on JFS Wealth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.